| pubmed-article:18578656 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18578656 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:18578656 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:18578656 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:18578656 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:18578656 | lifeskim:mentions | umls-concept:C1518601 | lld:lifeskim |
| pubmed-article:18578656 | lifeskim:mentions | umls-concept:C1550456 | lld:lifeskim |
| pubmed-article:18578656 | lifeskim:mentions | umls-concept:C1883420 | lld:lifeskim |
| pubmed-article:18578656 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18578656 | pubmed:dateCreated | 2008-6-26 | lld:pubmed |
| pubmed-article:18578656 | pubmed:abstractText | To discuss the merits of the endoscopic management of upper-tract transitional-cell carcinoma (UTTCC). We present original data from our institution over an 8-year period and a review of some of the world literature. A discussion of the overall suitability of this modality for both clinician and patient is presented. | lld:pubmed |
| pubmed-article:18578656 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18578656 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18578656 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18578656 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18578656 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18578656 | pubmed:issn | 1557-900X | lld:pubmed |
| pubmed-article:18578656 | pubmed:author | pubmed-author:TimoneyAnthon... | lld:pubmed |
| pubmed-article:18578656 | pubmed:author | pubmed-author:KeeleyFrancis... | lld:pubmed |
| pubmed-article:18578656 | pubmed:author | pubmed-author:PainterDaniel... | lld:pubmed |
| pubmed-article:18578656 | pubmed:author | pubmed-author:DentonKarinK | lld:pubmed |
| pubmed-article:18578656 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18578656 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:18578656 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18578656 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18578656 | pubmed:pagination | 1237-9 | lld:pubmed |
| pubmed-article:18578656 | pubmed:meshHeading | pubmed-meshheading:18578656... | lld:pubmed |
| pubmed-article:18578656 | pubmed:meshHeading | pubmed-meshheading:18578656... | lld:pubmed |
| pubmed-article:18578656 | pubmed:meshHeading | pubmed-meshheading:18578656... | lld:pubmed |
| pubmed-article:18578656 | pubmed:meshHeading | pubmed-meshheading:18578656... | lld:pubmed |
| pubmed-article:18578656 | pubmed:meshHeading | pubmed-meshheading:18578656... | lld:pubmed |
| pubmed-article:18578656 | pubmed:meshHeading | pubmed-meshheading:18578656... | lld:pubmed |
| pubmed-article:18578656 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18578656 | pubmed:articleTitle | Ureteroscopic management of upper-tract urothelial cancer: an exciting nephron-sparing option or an unacceptable risk? | lld:pubmed |
| pubmed-article:18578656 | pubmed:affiliation | Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom. danny_painter@hotmail.com | lld:pubmed |
| pubmed-article:18578656 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18578656 | lld:pubmed |
